ArticleFrontiers in nutrition2026
MENA Delphi consensus on iron deficiency anemia in infants and young children: screening, management, and prevention strategies.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Iron deficiency anemia (IDA) is one of the most prevalent and consequential nutritional disorders affecting infants and young children globally, with profound implications for neuro development and long-term health. Despite its well-documented risks, IDA remains under diagnosed and under treated, particularly in the Middle East and North Africa (MENA) region, where prevalence ranges from 23.2% in the UAE to 72% in Jordan. To address gaps in screening, diagnosis, and management, a multidisciplinary panel of 14 pediatric experts from nine MENA countries convened to develop evidence-based consensus recommendations. Methods: The methodology included a structured literature review, virtual consensus meetings, and iterative Delphi-style voting on 32 evidence-based statements across five domains: (1) prevalence and burden, (2) screening and diagnosis, (3) nutritional prevention, (4) treatment, and (5) public health strategies. Results: Key recommendations included universal screening at 9-12 months using hemoglobin, CRP, and ferritin; first-line oral iron therapy (3-6 mg/kg/day of elemental iron for 3-6 months); and avoidance of cow's milk before 12 months. The panel also developed a comprehensive algorithm to standardize diagnosis and management across the region. Major barriers identified were underutilized screening practices (85.71% agreement) and insufficient public awareness (92.86% emphasized tailored campaigns). Excessive and early cow's milk consumption was considered a key dietary contributor to IDA, with 84.6% agreement on its role due to low iron content and 69.2% agreement on its inhibitory effects on iron absorption and risk of gastrointestinal blood loss. Discussion: This consensus highlights critical interventions, including iron-rich complementary feeding, caregiver education, and referral for refractory cases. By aligning clinical practice with current evidence and regional realities, these consensus recommendations provide a structured framework to reduce the burden of IDA in MENA through early detection, standardized care, and collaborative public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.